hieroglyphic
发表于 2025-3-23 11:38:30
The Future of Risk Management, Volume IIC, while it is also claimed that CETP weakens atherosclerosis formation by promoting RCT. Currently, the CETP-related drugs are still immature. Research on CETP inhibitors is targeted at improving efficacy and minimizing adverse reactions. As for CETP agonists, research has proved that they also can be used to resist atherosclerosis.
Prologue
发表于 2025-3-23 17:52:01
http://reply.papertrans.cn/43/4202/420179/420179_12.png
温和女人
发表于 2025-3-23 20:28:48
http://reply.papertrans.cn/43/4202/420179/420179_13.png
包租车船
发表于 2025-3-24 00:27:11
https://doi.org/10.1007/978-1-349-20369-7lipoprotein (HDL) particles, and ABCG1 facilitates subsequent continued cholesterol efflux to HDL for further maturation. In this chapter, we summarize the roles of ABCA1 and ABCG1 in maintaining cellular cholesterol homoeostasis and discuss the underlying mechanisms by which they mediate cholesterol export.
Nostalgia
发表于 2025-3-24 04:31:42
http://reply.papertrans.cn/43/4202/420179/420179_15.png
大方一点
发表于 2025-3-24 06:55:42
http://reply.papertrans.cn/43/4202/420179/420179_16.png
态学
发表于 2025-3-24 13:03:33
HDL and Endothelial Function,ial functions, lots of cardiovascular diseases such as atherosclerosis could not be fully prevented and treated. Thus, a further understanding of the relationship between HDL and endothelial cell is needed, which would create a potential therapeutic approach to cardiovascular diseases.
fatty-streak
发表于 2025-3-24 16:43:06
http://reply.papertrans.cn/43/4202/420179/420179_18.png
Anthem
发表于 2025-3-24 21:23:18
ABCA1, ABCG1, and Cholesterol Homeostasis,lipoprotein (HDL) particles, and ABCG1 facilitates subsequent continued cholesterol efflux to HDL for further maturation. In this chapter, we summarize the roles of ABCA1 and ABCG1 in maintaining cellular cholesterol homoeostasis and discuss the underlying mechanisms by which they mediate cholesterol export.
分开
发表于 2025-3-25 03:12:19
HDL and Therapy, apolipoprotein mimetic peptides like apoA-I and and apoE mimetics have undergone clinical assessment, and we have also reviewed the advances of clinical trials and gave an outlook for the therapy of rHDL and mimetic peptides.